160 related articles for article (PubMed ID: 25267050)
21. The use of cardiovascular risk factor information in practice databases: making the best of patient data.
Marshall T
Br J Gen Pract; 2006 Aug; 56(529):600-5. PubMed ID: 16882378
[TBL] [Abstract][Full Text] [Related]
22. Effect of guideline revisions by the Swiss Society of Hypertension on blood pressure control in hypertensive patients from primary care.
Giezendanner S; Tschudi P; Leuppi J; Dieterle T; Zeller A
Swiss Med Wkly; 2020 Jun; 150():w20279. PubMed ID: 32657419
[TBL] [Abstract][Full Text] [Related]
23. Cost-Effectiveness of Drug Treatment for Chinese Patients With Stage I Hypertension According to the 2017 Hypertension Clinical Practice Guidelines.
Zhou YF; Liu N; Wang P; Jeong Yang J; Song XY; Pan XF; Zhang X; He M; Li H; Gao YT; Xiang YB; Wu T; Yu D; Pan A
Hypertension; 2020 Sep; 76(3):750-758. PubMed ID: 32713271
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular risk management in community-dwelling elderly: opportunities for prevention.
Ligthart SA; Richard E; van Gool WA; Moll van Charante EP
Eur J Prev Cardiol; 2012 Dec; 19(6):1365-72. PubMed ID: 21930719
[TBL] [Abstract][Full Text] [Related]
25. Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelines.
Balu S
Clin Ther; 2009 Jul; 31(7):1581-94. PubMed ID: 19695408
[TBL] [Abstract][Full Text] [Related]
26. Evaluating national guidelines for prevention of cardiovascular disease in primary care.
Marshall T
J Eval Clin Pract; 2005 Oct; 11(5):452-61. PubMed ID: 16164586
[TBL] [Abstract][Full Text] [Related]
27. Primary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines: A Retrospective Cohort Analysis.
Han X; Fox DS; Chu M; Dougherty JS; McCombs J
J Manag Care Spec Pharm; 2018 Nov; 24(11):1078-1085. PubMed ID: 30362921
[TBL] [Abstract][Full Text] [Related]
28. The cost-effectiveness of drug treatments for primary prevention of cardiovascular disease: a modelling study.
Marshall T
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):523-8. PubMed ID: 16874140
[TBL] [Abstract][Full Text] [Related]
29. Will changes in primary care improve health outcomes? Modelling the impact of financial incentives introduced to improve quality of care in the UK.
McElduff P; Lyratzopoulos G; Edwards R; Heller RF; Shekelle P; Roland M
Qual Saf Health Care; 2004 Jun; 13(3):191-7. PubMed ID: 15175489
[TBL] [Abstract][Full Text] [Related]
30. Comparative Cost-Effectiveness of Hypertension Treatment in Non-Hispanic Blacks and Whites According to 2014 Guidelines: A Modeling Study.
Vasudeva E; Moise N; Huang C; Mason A; Penko J; Goldman L; Coxson PG; Bibbins-Domingo K; Moran AE
Am J Hypertens; 2016 Oct; 29(10):1195-205. PubMed ID: 27172970
[TBL] [Abstract][Full Text] [Related]
31. Which elderly patients should be considered for anti-hypertensive treatment? An evidence-based approach.
Jackson R
J Hum Hypertens; 1998 Sep; 12(9):607-13. PubMed ID: 9783489
[TBL] [Abstract][Full Text] [Related]
32. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
33. Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.
Li C; Chen K; Cornelius V; Tomeny E; Wang Y; Yang X; Yuan X; Qin R; Yu D; Wu Z; Wang D; Chen T
PLoS Med; 2021 Mar; 18(3):e1003515. PubMed ID: 33661907
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project.
Sović N; Pająk A; Jankowski P; Duenas A; Kawecka-Jaszcz K; Wolfshaut-Wolak R; Stepaniak U; Kawalec P
Kardiol Pol; 2013; 71(7):702-11. PubMed ID: 23907903
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness analysis of guidelines for antihypertensive care in Finland.
Booth N; Jula A; Aronen P; Kaila M; Klaukka T; Kukkonen-Harjula K; Reunanen A; Rissanen P; Sintonen H; Mäkelä M
BMC Health Serv Res; 2007 Oct; 7():172. PubMed ID: 17958883
[TBL] [Abstract][Full Text] [Related]
36. Adding a low-dose antihypertensive regimen would substantially improve the control of hypertension and reduce cardiovascular morbidity among uncomplicated hypertensive patients.
Ahola TL; Kantola IM; Mäki J; Reunanen A; Jula AM
Eur J Prev Cardiol; 2012 Aug; 19(4):712-22. PubMed ID: 21609976
[TBL] [Abstract][Full Text] [Related]
37. Simulating the impact of improved cardiovascular risk interventions on clinical and economic outcomes in Russia.
Shum K; Alperin P; Shalnova S; Boytsov S; Kontsevaya A; Vigdorchik A; Guetz A; Eriksson J; Hughes D
PLoS One; 2014; 9(8):e103280. PubMed ID: 25141122
[TBL] [Abstract][Full Text] [Related]
38. Economic evaluation of primary prevention of cardiovascular diseases in mild hypertension: a scenario analysis for the Netherlands.
Stevanović J; O'Prinsen AC; Verheggen BG; Schuiling-Veninga N; Postma MJ; Pechlivanoglou P
Clin Ther; 2014 Mar; 36(3):368-84.e5. PubMed ID: 24534654
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Hypertension, Treatment, and Blood Pressure Targets in Canada Associated With the 2017 American College of Cardiology and American Heart Association Blood Pressure Guidelines.
Garies S; Hao S; McBrien K; Williamson T; Peng M; Khan NA; Padwal RS; Quan H; Leung AA;
JAMA Netw Open; 2019 Mar; 2(3):e190406. PubMed ID: 30848811
[TBL] [Abstract][Full Text] [Related]
40. A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study.
Simmons RK; Borch-Johnsen K; Lauritzen T; Rutten GE; Sandbæk A; van den Donk M; Black JA; Tao L; Wilson EC; Davies MJ; Khunti K; Sharp SJ; Wareham NJ; Griffin SJ
Health Technol Assess; 2016 Aug; 20(64):1-86. PubMed ID: 27583404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
